Literature DB >> 463182

75Se-release: a short and long term assay system for cellular cytoxicity.

W Leibold, S Bridge.   

Abstract

The gamma-emitting aminoacid 75Se-selenomethionine (75SeM) was examined as a target cell label in cytotoxic assays. It was efficiently taken up by activated, intensively metabolizing cells of various types but hardly at all by resting or low-metabolizing cells. Culturing activated cells in methionine-deficient medium with 3--5 mu Ci75SeM/ml for 18--22 h usually resulted in an uptake of 3--20 cpm/cell which was 3--200 times that of 51Cr marked cells. 75SeM-labelled cells kept in medium at ambient temperature or at 37 degrees C, maintained a high radioactivity per cell and a viability above 85% for at least 72 h without significant increase in spontaneous isotope release or loss in sensitivity in subsequent cytotoxic tests. 75Se-labelled material released from target cells was not reutilized by unlabelled lymphoid cells. Provided the cells were carefully washed after labelling and kept in optimal culture conditions, the reasonably low baseline release (usually 0.6--1.8% of input/h) in the medium control allowed performance of long-term assays of up to 54 h. However, strong cytotoxic reactions (e.g. ADCC) could cause over 50% specific 75Se-release within 5 h. With constant amounts of effector cells (3.6 x 10(3) up to 3 x 10(5)/well) identical or even higher, specific releases were obtained on 6 x 10(2) targets as compared to 1 x 10(4) targets/well. Thus, the 75Se-release assay offers a single monitoring system suitable for short (3--6 h) and long term (usually up to 44 h) cytotoxic reactions on a microscale, using 1 x 10(3) or less targets/well. Its sensitivity permits evaluation of strong and weak reactions as well as early and delayed onset cytotoxicity. In addition, with a gamma-spectrometer the radioactivity of 75Se can easily be distinguished from that of 51Cr. Due to this, and an improved method for 51Cr labelling of cells (10 mu Ci 51Cr/ml medium for 18--22 h), a double gamma-labelling of cellular proteins is available which provides new possibilities for monitoring cellular interactions in short and long term tests.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 463182

Source DB:  PubMed          Journal:  Z Immunitatsforsch Immunobiol        ISSN: 0340-904X


  9 in total

1.  Large granular lymphocytes: morphological and functional properties. I. Results in normals.

Authors:  G Gastl; F Schmalzl; D Huhn; C Gattringer; C Huber
Journal:  Blut       Date:  1983-06

2.  Inhibition of protein synthesis, pulmonary localization and pulmonary tumour formation by drug-treated tumour cells as a means of predicting their chemosensitivity.

Authors:  T Lai; B R Stonebridge; J Black; M O Symes
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

3.  Association between ICAM-1 expression and metastatic capacity of murine B-cell hybridomas.

Authors:  R G Hawley; M H Wang; A Z Fong; T S Hawley
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

4.  Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro.

Authors:  A Thanhäuser; A Böhle; H D Flad; M Ernst; T Mattern; A J Ulmer
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

5.  Intralymphatic interleukin-2 treatment of a hemophiliac AIDS patient with defective interleukin-2 production.

Authors:  M Gramatzki; G R Burmester; N Heyder; H G Nüsslein; W Rödl; W Grote; D A Monner; P F Mühlradt; J R Kalden
Journal:  Klin Wochenschr       Date:  1987-04-15

6.  Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML.

Authors:  C Huber; R Pfister; G Stingl
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

7.  Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity.

Authors:  A Thanhäuser; N Reiling; A Böhle; K M Toellner; M Duchrow; D Scheel; C Schlüter; M Ernst; H D Flad; A J Ulmer
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

8.  On the mode of action of intravesical bacillus Calmette-Guérin: in vitro characterization of BCG-activated killer cells.

Authors:  A Böhle; A Thanhäuser; A J Ulmer; T Mattern; M Ernst; H D Flad; D Jocham
Journal:  Urol Res       Date:  1994

9.  Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes.

Authors:  B Charley; H Laude; C La Bonnardière
Journal:  Ann Inst Pasteur Virol       Date:  2009-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.